2008
STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes
KREJČÍ, Pavel, Lisa SALAZAR, Helen GOODRIDGE, Tamara KASHIWADA, Matthew SCHIBLER et. al.Základní údaje
Originální název
STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes
Autoři
KREJČÍ, Pavel (203 Česká republika, garant, domácí), Lisa SALAZAR (840 Spojené státy), Helen GOODRIDGE (840 Spojené státy), Tamara KASHIWADA (840 Spojené státy), Matthew SCHIBLER (840 Spojené státy), Petra JELÍNKOVÁ (203 Česká republika), Leslie Michels THOMPSON, (840 Spojené státy) a William WILCOX (840 Spojené státy)
Vydání
JOURNAL OF CELL SCIENCE, 2008, 0021-9533
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
Genetika a molekulární biologie
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 6.247
Kód RIV
RIV/00216224:14310/08:00067178
Organizační jednotka
Přírodovědecká fakulta
UT WoS
000253425600004
Klíčová slova anglicky
FACTOR RECEPTOR-3 FGFR3; THANATOPHORIC DYSPLASIA; SERINE PHOSPHORYLATION; INHIBITS PROLIFERATION; INTERFERON-GAMMA; PC12 CELLS; ACTIVATION; INDUCTION; KINASE; APOPTOSIS
Změněno: 29. 4. 2014 09:44, prof. Ing. Petr Dvořák, CSc.
Anotace
V originále
Activating mutations in fibroblast growth factor receptor 3 (FGFR3) cause several human skeletal dysplasias as a result of attenuation of cartilage growth. It is believed that FGFR3 inhibits chondrocyte proliferation via activation of signal transducers and activators of transcription ( STAT) proteins, although the exact mechanism of both STAT activation and STAT-mediated inhibition of chondrocyte growth is unclear. We show that FGFR3 interacts with STAT1 in cells and is capable of activating phosphorylation of STAT1 in a kinase assay, thus potentially serving as a STAT1 kinase in chondrocytes. However, as demonstrated by western blotting with phosphorylation-specific antibodies, imaging of STAT nuclear translocation, STAT transcription factor assays and STAT luciferase reporter assays, FGF does not activate STAT1 or STAT3 in RCS chondrocytes, which nevertheless respond to a FGF stimulus with potent growth arrest. Moreover, addition of active STAT1 and STAT3 to the FGF signal, by means of cytokine treatment, SRC-mediated STAT activation or expression of constitutively active STAT mutants does not sensitize RCS chondrocytes to FGF-mediated growth arrest. Since FGF-mediated growth arrest is rescued by siRNA-mediated downregulation of the MAP kinase ERK1/2 but not STAT1 or STAT3, our data support a model whereby the ERK arm but not STAT arm of FGF signaling in chondrocytes accounts for the growth arrest phenotype.
Návaznosti
MSM0021622430, záměr |
|